National Price To Sales Ratio from 2010 to 2024

NRC Stock  USD 23.00  0.45  1.92%   
National Research's Price To Sales Ratio is decreasing over the years with stable fluctuation. Overall, Price To Sales Ratio is expected to go to 9.85 this year. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing National Research's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
6.53386997
Current Value
9.85
Quarterly Volatility
12.52211031
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check National Research financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National Research's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 M, Interest Expense of 1.5 M or Total Revenue of 156 M, as well as many indicators such as Price To Sales Ratio of 9.85, Dividend Yield of 0.0305 or PTB Ratio of 35.82. National financial statements analysis is a perfect complement when working with National Research Valuation or Volatility modules.
  
Check out the analysis of National Research Correlation against competitors.

Latest National Research's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of National Research Corp over the last few years. Price to Sales Ratio is figured by comparing National Research Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on National Research sales, a figure that is much harder to manipulate than other National Research Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. National Research's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National Research's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 4.11 X10 Years Trend
Pretty Stable
   Price To Sales Ratio   
       Timeline  

National Price To Sales Ratio Regression Statistics

Arithmetic Mean9.39
Geometric Mean6.41
Coefficient Of Variation133.37
Mean Deviation6.38
Median6.53
Standard Deviation12.52
Sample Variance156.80
Range51.382
R-Value(0.27)
Mean Square Error156.37
R-Squared0.07
Significance0.33
Slope(0.76)
Total Sum of Squares2,195

National Price To Sales Ratio History

2024 9.85
2023 6.53
2022 6.13
2021 7.13
2020 8.07
2019 12.78
2018 8.63

About National Research Financial Statements

National Research stakeholders use historical fundamental indicators, such as National Research's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although National Research investors may analyze each financial statement separately, they are all interrelated. For example, changes in National Research's assets and liabilities are reflected in the revenues and expenses on National Research's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in National Research Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 6.53  9.85 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in National Stock

When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:
Check out the analysis of National Research Correlation against competitors.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
0.48
Earnings Share
1.24
Revenue Per Share
6.052
Quarterly Revenue Growth
(0.03)
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.